BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7569499)

  • 1. Planning and revising the sample size for a trial.
    Gould AL
    Stat Med; 1995 May 15-30; 14(9-10):1039-51; discussion 1053-5. PubMed ID: 7569499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A SAS macro for sample size re-estimation.
    Zellner D; Zellner GE; Keller F
    Comput Methods Programs Biomed; 2001 Jun; 65(3):183-90. PubMed ID: 11339980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size re-estimation in group-sequential response-adaptive clinical trials.
    Morgan CC
    Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blinded sample size reestimation with negative binomial counts in superiority and non-inferiority trials.
    Friede T; Schmidli H
    Methods Inf Med; 2010; 49(6):618-24. PubMed ID: 20686735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blinded sample size reestimation with count data: methods and applications in multiple sclerosis.
    Friede T; Schmidli H
    Stat Med; 2010 May; 29(10):1145-56. PubMed ID: 20146203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On sample size estimation and re-estimation adjusting for variability in confirmatory trials.
    Wu PS; Lin M; Chow SC
    J Biopharm Stat; 2016; 26(1):44-54. PubMed ID: 26378970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interim analyses for monitoring clinical trials that do not materially affect the type I error rate.
    Gould AL
    Stat Med; 1992 Jan; 11(1):55-66. PubMed ID: 1557576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modifying the design of ongoing trials without unblinding.
    Gould AL; Shih WJ
    Stat Med; 1998 Jan; 17(1):89-100. PubMed ID: 9463852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stopping boundaries adjusted for sample size reestimation and negative stop.
    Shun Z
    J Biopharm Stat; 2002 Nov; 12(4):485-502. PubMed ID: 12477071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blinded sample size recalculation for clinical trials with normal data and baseline adjusted analysis.
    Friede T; Kieser M
    Pharm Stat; 2011; 10(1):8-13. PubMed ID: 19943322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blinded sample size recalculation in clinical trials with binary composite endpoints.
    Sander A; Rauch G; Kieser M
    J Biopharm Stat; 2017; 27(4):705-715. PubMed ID: 27295402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design for sample size re-estimation with interim data for double-blind clinical trials with binary outcomes.
    Shih WJ; Zhao PL
    Stat Med; 1997 Sep; 16(17):1913-23. PubMed ID: 9304763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An internal pilot design for prospective cancer screening trials with unknown disease prevalence.
    Brinton JT; Ringham BM; Glueck DH
    Trials; 2015 Oct; 16():458. PubMed ID: 26463684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internal pilot studies for estimating sample size.
    Birkett MA; Day SJ
    Stat Med; 1994 Dec 15-30; 13(23-24):2455-63. PubMed ID: 7701146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Sample Size by Bootstrap and by Formulas Based on Normal Distribution Assumption.
    Wang Z
    Ther Innov Regul Sci; 2019 Mar; 53(2):170-175. PubMed ID: 29807472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance, Errors, Power, and Sample Size: The Blocking and Tackling of Statistics.
    Mascha EJ; Vetter TR
    Anesth Analg; 2018 Feb; 126(2):691-698. PubMed ID: 29346210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential designs with small samples: Evaluation and recommendations for normal responses.
    Nikolakopoulos S; Roes KC; van der Tweel I
    Stat Methods Med Res; 2018 Apr; 27(4):1115-1127. PubMed ID: 27342574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A decision theoretic approach to sample size determination in clinical trials.
    Gittins JC; Pezeshk H
    J Biopharm Stat; 2002 Nov; 12(4):535-51. PubMed ID: 12477073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blinded sample size recalculation in multicentre trials with normally distributed outcome.
    Jensen K; Kieser M
    Biom J; 2010 Jun; 52(3):377-99. PubMed ID: 20394080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-evaluating design specifications of longitudinal clinical trials without unblinding when the key response is rate of change.
    Shih WJ; Gould AL
    Stat Med; 1995 Oct; 14(20):2239-48. PubMed ID: 8552900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.